Home/Filings/4/0001209191-24-002500
4//SEC Filing

KERINS PATRICK J 4

Accession 0001209191-24-002500

CIK 0001400118other

Filed

Jan 30, 7:00 PM ET

Accepted

Jan 31, 4:59 PM ET

Size

11.6 KB

Accession

0001209191-24-002500

Insider Transaction Report

Form 4
Period: 2024-01-29
Transactions
  • Other

    Series A Common Stock

    2024-01-29850,0003,000,275 total(indirect: See Note 2)
  • Other

    Series A Common Stock

    2024-01-29+260,950260,950 total(indirect: See Note 4)
  • Other

    Series A Common Stock

    2024-01-29260,9500 total(indirect: See Note 4)
  • Other

    Series A Common Stock

    2024-01-29+13,13913,139 total
Footnotes (6)
  • [F1]New Enterprise Associates 13, L.P. ("NEA 13") made a pro rata distribution of 850,000 shares of Series A Common Stock of the Issuer to its general partner and limited partners for no consideration on January 29, 2024.
  • [F2]The Reporting Person is a director of NEA 13 GP, LTD ("NEA 13 LTD"), which is the sole general partner of NEA Partners 13, L.P. ("NEA Partners 13"). NEA Partners 13 is the sole general partner of NEA 13, which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 13 in which the Reporting Person has no pecuniary interest.
  • [F3]NEA Partners 13 received 260,950 shares of Series A Common Stock of the Issuer in the distribution made by NEA 13 on January 29, 2024.
  • [F4]The Reporting Person is a director of NEA 13 LTD, the sole general partner of NEA Partners 13, the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA Partners 13 in which the Reporting Person has no pecuniary interest.
  • [F5]NEA Partners 13 made a pro rata distribution for no consideration of an aggregate of 260,950 shares of Series A Common Stock of the Issuer to its limited partners on January 29, 2024.
  • [F6]The Reporting Person received 13,139 shares of Series A Common Stock of the Issuer in the distribution by NEA Partners 13 on January 29, 2024.

Issuer

Sagimet Biosciences Inc.

CIK 0001400118

Entity typeother

Related Parties

1
  • filerCIK 0001235112

Filing Metadata

Form type
4
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 4:59 PM ET
Size
11.6 KB